ChinaAMC Hang Seng Hong Kong Biotech Index ETF (03069.HK) Falls 0.66%, Turnover Reaches HKD 61.6949 Million
Newtimespace News: As of 15:23 on June 22, ChinaAMC Hang Seng Hong Kong Biotech Index ETF (03069.HK) stood at HKD 12.050, down 0.66%. The ETF opened at HKD 12.200, with the latest net asset value (NAV) at HKD 12.222, a discount of 0.75%, a turnover of approximately HKD 61.6949 million, and assets under management of approximately HKD 1.848 billion.
ChinaAMC Hang Seng Hong Kong Biotech Index ETF (03069.HK) closely tracks the Hang Seng Hong Kong Listed Biotech Index. The index covers 50 biotech companies listed in Hong Kong, focusing on pharmaceuticals, biotechnology, medical equipment, and other fields, capturing innovative growth opportunities in the Hong Kong biotech sector.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- Chinaamc Hang Seng Hong Kong Biotech Index ETF (03069.HK) Rises 6.05% in Morning Trade, Turnover at HKD 420 Million
- Chinaamc Hang Seng Hong Kong Biotech Index ETF (03069.HK) rises 0.92% intraday, NAV per unit at HK$15.311
- Chinaamc Hang Seng Hong Kong Biotech Index ETF (03069.HK) Rises 2.50% in Morning Trade, Turnover Reaches HKD 22.7500 Million
- Chinaamc Hang Seng Hong Kong Biotech Index ETF (03069.HK) Rises 2.28% in Morning Trade, Turnover Reaches HKD 41.2817 Million
- ChinaAMC Hang Seng Hong Kong Biotech Index ETF (03069.HK) Rises 2.23%, Turnover Reaches HKD 69.5437 Million